Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elias Björnson

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Atherosclerosis|August 13, 2025
Lp(a) variability untangled: It's the benchwork, not the biologyElias Björnson
European Heart Journal|April 9, 2026
Risk-weighted apoB: the evidence on the scalesMichaela B Rehman, Elias Björnson
Frontiers in Physiology|February 10, 2016
Personalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine ToolsElias Björnson, Jan Borén, Adil Mardinoglu
European Journal of Preventive Cardiology|December 17, 2025
'Genetic modelling of triglyceride-rich lipoprotein/remnant lowering mimics APOC3-silencing and predicts clinically relevant coronary heart disease event reductions': author's responseElias Björnson, Jan Borén, Chris Packard
Pharmacology & Therapeutics|February 22, 2026
Clinical relevance of per-particle atherogenicity of triglyceride-rich lipoproteins, Lp(a) and LDL for cardiovascular riskElias Björnson, Chris J Packard, Jan Borén
Lakartidningen|March 20, 2026
[Lipoprotein(a) - the hereditary risk factor for cardiovascular disease]Elias Björnson, Jonas Brinck, Emil Hagström, et al.
Atherosclerosis|December 15, 2023
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteinsElias Björnson, Martin Adiels, Göran Bergström, et al.
Current Opinion in Lipidology|November 30, 2016
Kinetics of plasma triglycerides in abdominal obesityElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Current Opinion in Cardiology|October 3, 2024
Lipoprotein(a) is a highly atherogenic lipoprotein: pathophysiological basis and clinical implicationsElias Björnson, Martin Adiels, Jan Borén, et al.
Journal of Cardiovascular Translational Research|October 10, 2025
Plasma Proteomics for Predicting Cardiovascular Disease: How Many Proteins are Enough?Patrick Royer, Elias Björnson, Martin Adiels, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Atherosclerosis|August 13, 2025
Lp(a) variability untangled: It's the benchwork, not the biologyElias Björnson
European Heart Journal|April 9, 2026
Risk-weighted apoB: the evidence on the scalesMichaela B Rehman, Elias Björnson
Frontiers in Physiology|February 10, 2016
Personalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine ToolsElias Björnson, Jan Borén, Adil Mardinoglu
European Journal of Preventive Cardiology|December 17, 2025
'Genetic modelling of triglyceride-rich lipoprotein/remnant lowering mimics APOC3-silencing and predicts clinically relevant coronary heart disease event reductions': author's responseElias Björnson, Jan Borén, Chris Packard
Pharmacology & Therapeutics|February 22, 2026
Clinical relevance of per-particle atherogenicity of triglyceride-rich lipoproteins, Lp(a) and LDL for cardiovascular riskElias Björnson, Chris J Packard, Jan Borén
Lakartidningen|March 20, 2026
[Lipoprotein(a) - the hereditary risk factor for cardiovascular disease]Elias Björnson, Jonas Brinck, Emil Hagström, et al.
Atherosclerosis|December 15, 2023
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteinsElias Björnson, Martin Adiels, Göran Bergström, et al.
Current Opinion in Lipidology|November 30, 2016
Kinetics of plasma triglycerides in abdominal obesityElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Current Opinion in Cardiology|October 3, 2024
Lipoprotein(a) is a highly atherogenic lipoprotein: pathophysiological basis and clinical implicationsElias Björnson, Martin Adiels, Jan Borén, et al.
Journal of Cardiovascular Translational Research|October 10, 2025
Plasma Proteomics for Predicting Cardiovascular Disease: How Many Proteins are Enough?Patrick Royer, Elias Björnson, Martin Adiels, et al.
Pageof 6